Table 1.

Baseline characteristics of the study group with IgAN

	Total (n = 105)
Age (year)	34.73 ± 12.19
Male (n/%)	57(54.3 %)
Smoker (n/%)	32(30.5 %)
Body mass index (kg/m2)	23.2 ± 3.18
Systolic blood pressure (mmHg)	131.21 ± 23.43
Diastolic blood pressure (mmHg)	81.57 ± 16.84
Microscopic hematuria (n/%)	67 (63.8 %)
Proteinuria(g/24 h)	2.04 ± 1.09
eGFR (mL/min/1.73 m2)	75.45 ± 39.18
Serum albumin (mg/dL)	33.88 ± 7.91
Serum total cholesterol (mg/dL)	5.76 ± 2.09
Serum IgA (mg/dL)	2.97 ± 1.92
Uric acid (mg/dL)	404.81 ± 123.59
Medical treatment (n/%)
RAS blockers	83 (79 %)
Immunosuppressant	38 (36.2 %)

Data are presented as mean ± SD. eGFR, estimated glomerular filtration rate; IgAN, IgA nephropathy; RAS, renin-angiotensin system